You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HLA-A*02

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +19 more
  • A2B694
  • xT CDx with HLA-LOH Assay
  • Duarte, California
  • +9 more
Sep 22, 2023

Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +15 more
  • A2B530
  • xT-Onco with HLA-LOH Assay
  • Duarte, California
  • +6 more
Feb 10, 2023

NSCLC, Head and Neck Squamous Cell Carcinoma, Colorectal Carcinoma Trial in Duarte (Autologous, engineered T Cells targeting

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +5 more
  • Autologous, engineered T Cells targeting TP53 R175H
  • Duarte, California
    City of Hope
May 17, 2023

Soft Tissue Sarcoma Trial in Guangzhou, Beijing (NY-ESO-1(TCR Affinity Enhancing Specific T cell Therapy))

Recruiting
  • Soft Tissue Sarcoma
  • NY-ESO-1(TCR Affinity Enhancing Specific T cell Therapy)
  • Guangzhou, Guangdong, China
  • +1 more
Sep 18, 2022

Advanced Solid Tumors Trial in Belgium, Germany, Spain (Autologous CD8+ T-cells, transduced with MAGE-A1 directed TCR)

Recruiting
  • Advanced Solid Tumors
  • Autologous CD8+ T-cells, transduced with MAGE-A1 directed TCR
  • Ghent, Belgium
  • +2 more
Jun 23, 2022

Advanced Melanoma Trial (Tebentafusp, Tebentafusp with Pembrolizumab, Investigators Choice)

Not yet recruiting
  • Advanced Melanoma
  • (no location specified)
Sep 19, 2022

Uveal Melanoma Trial (Tebentafusp)

Available
  • Uveal Melanoma
  • (no location specified)
Jan 5, 2022

Adult Solid Tumor Trial in Spain, United States (SQZ-AAC-HPV, Ipilimumab, Nivolumab)

Recruiting
  • Adult Solid Tumor
  • SQZ-AAC-HPV
  • +2 more
  • Duarte, California
  • +5 more
Aug 12, 2022

Cancer of Head and Neck, Cancer of Cervix, Cancer of Anus Trial in Boston (DPX-E7 vaccine)

Active, not recruiting
  • Cancer of Head and Neck
  • +2 more
  • DPX-E7 vaccine
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Feb 18, 2022

Soft Tissue Sarcoma Trial in Guangzhou (TAEST16001 cells)

Active, not recruiting
  • Soft Tissue Sarcoma
  • TAEST16001 cells
  • Guangzhou, Guangdong, China
    Xing Zhang
Dec 13, 2022

Adult Solid Tumor Trial in Canada, Germany, United States (SQZ-PBMC-HPV, Atezolizumab, Ipilimumab)

Active, not recruiting
  • Adult Solid Tumor
  • SQZ-PBMC-HPV
  • +3 more
  • Scottsdale, Arizona
  • +12 more
Jan 17, 2023

Hepatitis B, Chronic Trial in Worldwide (IMC-I109V-101 Single Ascending Dose, IMC-I109V-101 Multiple Ascending Doses)

Recruiting
  • Hepatitis B, Chronic
  • IMC-I109V-101 Single Ascending Dose
  • IMC-I109V-101 Multiple Ascending Doses
  • Los Angeles, California
  • +19 more
May 10, 2023

Advanced Melanoma Trial in Worldwide (IMC-F106C, Nivolumab, Nivolumab + Relatlimab)

Not yet recruiting
  • Advanced Melanoma
  • IMC-F106C
  • +2 more
  • La Jolla, California
  • +61 more
Oct 31, 2023

Trifecta-Kidney cfDNA-MMDx Study

Recruiting
  • Kidney Transplant Rejection
  • MMDx
  • +2 more
  • Tampa, Florida
  • +30 more
Oct 12, 2022

Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in

Not yet recruiting
  • Head and Neck Cancer
  • +8 more
  • Tumor and HLA Profiling
  • (no location specified)
Mar 31, 2023

Solid Tumor Trial in Houston (Single Injection of IVS-3001- Anti - HLA-G CAR-T cells, Fludarabine phosphate, Cyclophosphamide)

Not yet recruiting
  • Solid Tumor
  • Single Injection of IVS-3001- Anti - HLA-G CAR-T cells
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 19, 2023

Metastatic Uveal Melanoma Trial in Grand Rapids (IDE196, Crizotinib, Pembrolizumab)

Recruiting
  • Metastatic Uveal Melanoma
  • Grand Rapids, Michigan
    The Cancer and Hematology Centers
Aug 14, 2023

Uveal Melanoma Trial in Pittsburgh (Tebentafusp)

Not yet recruiting
  • Uveal Melanoma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Oct 5, 2023

Severe Aplastic Anemia Trial (Busulfan, Flu/Cy/ATG or Cy/ATG)

Not yet recruiting
  • Severe Aplastic Anemia
  • (no location specified)
Oct 1, 2023

Ependymoma Trial in Pittsburgh (biological, drug, other)

Recruiting
  • Ependymoma
  • HLA-A2 restricted synthetic tumor antigen
  • +5 more
  • Pittsburgh, Pennsylvania
    Children's Hospital of Pittsburgh of UPMC
Oct 23, 2022

Amyloidosis; Systemic Trial in Woolloongabba, Box Hill (AT02)

Not yet recruiting
  • Amyloidosis; Systemic
  • Woolloongabba, Queensland, Australia
  • +1 more
Jul 11, 2023

Ovarian Cancer Trial (Autologous genetically modified ADP-A2M4CD8 cells, Autologous genetically modified ADP-A2M4CD8 cells in

Not yet recruiting
  • Ovarian Cancer
  • Autologous genetically modified ADP-A2M4CD8 cells
  • Autologous genetically modified ADP-A2M4CD8 cells in combination with Nivolumab
  • (no location specified)
Jan 31, 2023

HLA-DQA1*05 Genotype in Anti-TNF Treatment With Proactive

Recruiting
  • Drug Monitoring
  • Inflammatory Bowel Diseases
  • Tumor necrosis factor (TNF)-alpha inhibitors
  • Valladolid, Spain
    Hospital Universitario Rio Hortega
Aug 8, 2023

Breast Cancer Trial in United States (Placebo, GLSI-100)

Recruiting
  • Breast Cancer
  • Placebo
  • GLSI-100
  • Birmingham, Alabama
  • +21 more
Jan 30, 2023

Antibody-mediated Rejection, Cardiac Transplant Trial in Rochester (Daratumumab and hyaluronidase-fihj)

Enrolling by invitation
  • Antibody-mediated Rejection
  • Cardiac Transplant
  • Daratumumab and hyaluronidase-fihj
  • Rochester, Minnesota
    Mayo Clinic Rochester
Apr 11, 2022